Freshfields Bruckhaus Deringer advised Indivumed GmbH on the deal while Sidley is represented Crown Bioscience. Indivumed GmbH sold its “IndivuServ” business unit to a wholly owned...
Crown Bioscience’s Acquisition of Indivumed’s CRO Services Business
Arthur J. Gallagher & Co.’s US$3.57 Billion Acquisition of Willis Towers Watson Assets
Sidley Austin LLP and Skrine advised Arthur J. Gallagher & Co. on the deal. Arthur J. Gallagher & Co. announced its acquisition of certain Willis Towers Watson...